29 March 2012
Eurovestech plc
(the "Company")
Charitable Donations
Further to the announcement made earlier today, the Company announces that it
has issued 1,100,000 new ordinary shares in the issued share capital of
Eurovestech (the "Charity Shares") as follows;
Number of Ordinary
Shares
Battersea Dogs and Cats Home 100,000
Chris Westwood Charity for Children with Physical 100,000
Disabilities
Marie Curie Cancer Care 100,000
Metropolitan Sports and Social Club for the Visually 100,000
Impaired
Missing People 100,000
St Luke's Hospice 100,000
The Roy Castle Lung Cancer Foundation 100,000
The Royal Opera House Foundation (Apprenticeship) 100,000
Tracks Autism 100,000
The Trussell Trust 100,000
Yechi Am Yisrael 100,000
Richard Bernstein, Chief Executive of the Company, has paid the £11,000 to
facilitate their issue, representing the nominal value of these shares of 1
pence per share. Application has been made for the Charity Shares to be
admitted to AIM and it is expected that dealings will commence on 5 April 2012.
Following admission, the Company will have 332,050,000 ordinary shares in
issue.
ENQUIRIES:
Eurovestech plc
Richard Bernstein Tel: 020 7478 9070
Merchant Securities Limited (NOMAD)
David Worlidge/Simon Clements Tel: 020 7628 2200
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.